Targeting adenosine kinase for the prevention of post-traumatic epilepsy
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210638
- Recipient
-
Rutgers, The State University UEI MG5BM5RM42J9 Part of Rutgers, The State University
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $751,587
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025.
The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care. This award will allow Rutgers researchers to investigate medical solutions for preventing epilepsy following traumatic brain injuries sustained on the battlefield. The results have the potential to benefit both service members and civilians.
Quick answers
Who received award W81XWH2210638?
W81XWH2210638 was awarded to Rutgers, The State University by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210638 worth?
$751,587 has been obligated on W81XWH2210638.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award